Core Insights - Lakeside Holding Limited has announced a strategic distribution agreement with Sichuan Huiyu Pharmaceutical Co., Ltd. to distribute oncology and immunotherapy drugs [1][3] - Huiyu Pharmaceutical is recognized for its innovative therapies and strong R&D capabilities, particularly in oncology [2] - The flagship product of Huiyu Pharmaceutical, Pemetrexed Disodium for Injection, is approved in major markets and is effective in treating non-small cell lung cancer and malignant pleural mesothelioma [3] Company Overview - Lakeside Holding Limited is a U.S.-based cross-border supply chain solution provider focused on the Asia-Pacific market [5] - The company operates through two subsidiaries: American Bear Logistics and Hupan Pharmaceutical (Hubei) Co., Ltd., providing tailored logistics solutions [5] - American Bear Logistics connects Asia-based logistics service companies and e-commerce platforms with the U.S. market through strategic hubs [6] Strategic Developments - The acquisition of Hupan Pharmaceutical enhances Lakeside's pharmaceutical logistics and distribution capabilities within China [7] - The partnership with Huiyu Pharmaceutical aims to improve patient outcomes by providing reliable distribution channels for therapies [4]
Lakeside Partners with Huiyu Pharmaceutical to Revolutionize Oncology Drug Distribution